Vertex Pharmaceuticals (VRTX) Inventory (2011 - 2026)

Vertex Pharmaceuticals' Inventory history runs 16 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Inventory rose 29.93% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (up 29.93% YoY), while the FY2025 annual figure was $1.7 billion, up 39.94% from the prior year.
• Inventory for Q1 2026 stood at $1.8 billion, up from $1.7 billion in the prior quarter.
• The five-year high for Inventory was $1.8 billion in Q1 2026, with the low at $338.9 million in Q1 2022.
• The 5-year median for Inventory is $813.1 million (2024), against an average of $945.5 million.
• The sharpest annual moves came in 2022 and 2023: Inventory rose 13.4% in 2022, then surged 77.41% in 2023.
• Vertex Pharmaceuticals' Inventory stood at $460.6 million in 2022, then jumped by 60.4% to $738.8 million in 2023, then surged by 63.16% to $1.2 billion in 2024, then soared by 39.94% to $1.7 billion in 2025, then gained by 4.74% to $1.8 billion in 2026.
• Business Quant data shows VRTX's Inventory at $1.8 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.6 billion in Q3 2025.